74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Stevanato Group SpA
Closed
SectorHealthcare
22.42 1.04
Overview
Share price change
24h
Min
22.35
Max
22.76
Income | 4M 39M |
|---|---|
Sales | 23M 280M |
P/E Sector Avg | 38.333 34.427 |
Dividend yield | 0.23 |
Profit margin | 13.965 |
Employees | 5,521 |
EBITDA | 5.2M 62M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +21.57% upside |
Dividend yield Sector Avg | 0.23% 2.47% |
|---|---|
Next Earnings | 4 Nov 2025 |
Market Cap | -1B 6B |
|---|---|
Previous open | 21.38 |
Previous close | 22.42 |
News Sentiment
By Acuity
50%
50%
157 / 374 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Stevanato Group SpA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Stevanato Group SpA Forecast
Price Target
By TipRanks
21.57% upside
12 Months Forecast
Average 27.5 USD 21.57%
High 32 USD
Low 23.5 USD
Based on 6 Wall Street analysts offering 12 month price targets forStevanato Group SpA - Dist in the last 3 months.
Sentiment
By Acuity
157 / 374 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
